Low Incidence of Rejection and <i>De Novo</i> Donor‐Specific Antibody Formation Following <scp>COVID</scp> ‐19 Vaccination or Infection Among Pediatric Kidney Transplant Recipients
In our small single-center cohort, SARS-CoV-2 vaccination or infection is unlikely to increase the risk for rejection or de novo DSA in pediatric kidney transplant recipients. Larger prospective studies with a control group are needed to further understand the immune effects of the COVID-19 vaccine and disease in this population.
Authors
- Kelly Kirshner
- Helen Pizzo (ORCID: https://orcid.org/0000-0003-2997-7483)
- Jonathan Garrison (ORCID: https://orcid.org/0000-0002-9066-4497)
- Dechu Puliyanda (ORCID: https://orcid.org/0000-0002-6988-8533)
Institutions
- Cedars-Sinai Medical Center (US)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/petr.70084
- Citations
- 1
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.99